Oscar Health gains as outlook tops consensus despite Obamacare headwinds
Oscar Health (OSCR) shares rose after the company provided a 2026 revenue outlook exceeding consensus, despite challenges from Obamacare premium hikes. The firm reported a Q4 2025 GAAP loss of $1.24 per share on $2.8B revenue, missing estimates by $310M. CEO Mark Bertolini emphasized a focus on returning to profitability in 2026, projecting $250M-$450M in earnings from operations on $18.7B-$19.0B revenue. CFO Richard Blackley noted a 28% average rate increase for 2026, with expected elevated churn due to higher premiums. The company anticipates an improved medical loss ratio for 2026.
Source: businessinsider The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments